Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...

Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders: Our Bureau, Mumbai Tuesday, January 28, 2025, 16:45 Hrs [IST] Global pharma major Lupin Lim ...

Lupin and Avas Launch NaMuscla® in Italy Enables expanded access to the only EU-approved treatment for the myotonia symptoms in adults with non-dystrophic myotonic disorders Mumbai, Zug, January ...

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

AM (IST) on Wednesday, 0.62 per cent from previous close. The stock quoted a 52-week low price of Rs 1411.15 and a high of Rs ...

Lupin Ltd share price was down by -0.79% from the previous closing price of ₹2,151.20. Who are peers of Lupin Ltd? The peers of Lupin Ltd are Sun Pharmaceuticals Industries Ltd, Divis ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Lupin Share Price: Shares of pharmaceutical major Lupin Limited hit their 52-week high on the last trading day of calendar year 2024. The BSE 100 listed stock rallied around 2.5 per cent during ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...

Lupin and Avas Launch NaMuscla® in Italy Enables expanded access to the only EU-approved treatment for the myotonia symptoms ...